During the past decade, St. George Hospital conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 48 clinical trials were completed, i.e. on average, 45.3% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 26 clinical trials were completed. i.e. 52% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. George Hospital" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Gilead Sciences" with 10 trials sponsored, "Trans Tasman Radiation Oncology Group" with 8 trials sponsored, "BeiGene" with 7 trials sponsored and "Australasian Gastro-Intestinal Trials Group" with 7 trials sponsored. Other sponsors include 127 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. George Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 15 trials as a collaborator, "St George Hospital, Australia" with 7 trials as a collaborator, "The George Institute" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator and "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 217 different institutions and companies that were collaborators in the rest 177 trials.

According to Clinical.Site data, the most researched conditions in "St. George Hospital" are "Breast Cancer" (7 trials), "Prostate Cancer" (6 trials), "Non-Small Cell Lung Cancer" (5 trials), "Acute Myeloid Leukemia" (4 trials) and "Bronchiectasis" (4 trials). Many other conditions were trialed in "St. George Hospital" in a lesser frequency.

Most popular intervention types in "St. George Hospital" are "Drug" (135 trials), "Biological" (16 trials), "Other" (16 trials), "Device" (13 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Docetaxel" (9 trials), "Rituximab" (7 trials), "Carboplatin" (6 trials) and "Zanubrutinib" (5 trials). Other intervention names were less common.

The vast majority of trials in "St. George Hospital" are 156 trials for "All" genders, 11 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "St. George Hospital". undefined are not yet recruiting, 35 are recruiting, 33 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 81 completed trials in St. George Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in St. George Hospital, 16 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 24 trials that are defined as “Not Applicable".